Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Radiation Biology
•
General Radiation Oncology
Do patients with homocystinuria have an increase risk of radiation toxicity?
Would one expect a higher risk of rad effects?
Related Questions
Are there any precautions you would take when radiating the pelvis in an obese patient with recent extensive ventral hernia repair to minimize dehiscence risk?
Has there been an observed interaction between ACE inhibitors and development of angioedema in a block demarcated superficial radiation therapy treatment volume (ex. lip)?
How do you manage intradural - extramedullary metastases of the spinal cord from non-CNS malignancies?
How do you manage a patient's pain from the skin tattoos placed at CT simulation?
When do you offer adjuvant radiation therapy for a glomus tumor of uncertain malignant potential of the extremity resected with negative margins?
With the addition of pembrolizumab following chemoradiation per KEYNOTE-A18, would you be less likely to treat the paraaortic chain prophylactically?
Do you routinely offer spine SBRT for vertebral metastases regardless of overall patient disease burden or response?
What is the expected timeframe for the development of radiation myelitis and therapies that have helped with neurologic symptoms?
What is your preferred fractionation scheme for spine SBRT for radioresistant histologies?
Would you re-irradiate a spleen with increasing splenomegaly for a patient with myelofibrosis?
